Skip to content Skip to footer

Research Portal of the TU Dresden

Journal for ImmunoTherapy of Cancer

ISSNs: 2051-1426

BMJ Publishing Group

Scopus rating (2023): CiteScore 17.7 SJR 3.728 SNIP 1.645

Indexed in DOAJ

Journal

Titles	Journal for ImmunoTherapy of Cancer Journal for immunotherapy of cancer
Additional searchable titles	Journal for immunotherapy of cancer, J Immunother
ISSNs	2051-1426
Publisher	BMJ Publishing Group
ZDB-ID	2719863-7

Keywords

ASJC Scopus subject areas

Library keywords

610 Medicine and health

Related content

Research output

Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanoma

Hornsteiner, F., Vierthaler, J., Strandt, H., Resag, A., Fu, Z., Ausserhofer, M., Tripp, C. H., & 16 othersDieckmann, S., Kanduth, M., Farrand, K., Bregar, S., Nemati, N., Hermann-Kleiter, N., Seretis, A., Morla, S., Mullins, D., Finotello, F., Trajanoski, Z., Wollmann, G., Ronchese, F., Schmitz, M., Hermans, I. F. & Stoitzner, P., 17 Apr 2024, In: Journal for immunotherapy of cancer. 12, 4, e008606.

Research output: Contribution to journal › Research article › Contributed › peer-review

High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma

Rischin, D., Hughes, B. G. M., Basset-Séguin, N., Schadendorf, D., Bowyer, S., Trabelsi Messai, S., Meier, F., & 20 othersEigentler, T. K., Casado Echarren, V., Stein, B., Beylot-Barry, M., Dalac, S., Dréno, B., Migden, M. R., Hausschild, A., Schmults, C. D., Lim, A. M., Yoo, S. Y., Paccaly, A. J., Papachristos, A., Nguyen, J. H., Okoye, E., Seebach, F., Booth, J., Lowy, I., Fury, M. G. & Guminski, A., 11 Mar 2024, In: Journal for immunotherapy of cancer. 12, 3, e008325.

Research output: Contribution to journal › Research article › Contributed › peer-review

Treatment management for BRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG

Haist, M., Stege, H., Rogall, F., Tan, Y., von Wasielewski, I., Klespe, K. C., Meier, F., & 33 othersMohr, P., Kähler, K. C., Weichenthal, M., Hauschild, A., Schadendorf, D., Ugurel, S., Lodde, G., Zimmer, L., Gutzmer, R., Debus, D., Schilling, B., Kreuter, A., Ulrich, J., Meiss, F., Herbst, R., Forschner, A., Leiter, U., Pfoehler, C., Kaatz, M., Ziller, F., Hassel, J. C., Tronnier, M., Sachse, M., Dippel, E., Terheyden, P., Berking, C., Heppt, M. V., Kiecker, F., Haferkamp, S., Gebhardt, C., Simon, J. C., Grabbe, S. & Loquai, C., Sept 2023, In: Journal for immunotherapy of cancer. 11, 9, e007630.

Research output: Contribution to journal › Research article › Contributed › peer-review

Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study

Hamid, O., Hassel, J. C., Shoushtari, A. N., Meier, F., Bauer, T. M., Salama, A. K. S., Kirkwood, J. M., & 9 othersAscierto, P. A., Lorigan, P. C., Mauch, C., Orloff, M., Evans, T. R. J., Holland, C., Edukulla, R., Abedin, S. E. & Middleton, M. R., 7 Jun 2023, In: Journal for immunotherapy of cancer. 11, 6, e006747.

Research output: Contribution to journal › Research article › Contributed › peer-review

Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma

Gaißler, A., Bochem, J., Spreuer, J., Ottmann, S., Martens, A., Amaral, T., Wagner, N. B., & 8 othersClaassen, M., Meier, F., Terheyden, P., Garbe, C., Eigentler, T., Weide, B., Pawelec, G. & Wistuba-Hamprecht, K., Jun 2023, In: Journal for immunotherapy of cancer. 11, 6, e006802.

Research output: Contribution to journal › Research article › Contributed › peer-review

View all research output (8)